• All sections
  • C - Chemistry; metallurgy
  • C07C - Acyclic or carbocyclic compounds
  • C07C 271/20 - Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups

Patent holdings for IPC class C07C 271/20

Total number of patents in this class: 307

10-year publication summary

32
23
29
30
23
21
20
24
23
6
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
Arbutus Biopharma Corporation
183
15
Mitsui Chemicals, Inc.
3134
10
Modernatx, Inc.
1181
10
Nissan Chemical Industries, Ltd.
1822
8
Suzhou Abogen Biosciences Co., Ltd.
49
8
SK Biopharmaceuticals Co., Ltd.
248
7
Ambergen, Inc.
39
6
MedImmune Limited
627
6
Sutro Biopharma, Inc.
148
6
Sun Medical Co., Ltd.
44
5
Novartis AG
11238
4
Carnegie Mellon University
1405
4
Covestro Deutschland AG
2429
4
Curza Global, LLC
29
4
SynAffix B.V.
89
4
Texas Heart Institute
105
4
University of Utah Research Foundation
1737
4
Etherna Immunotherapies NV
43
4
Hoffmann-La Roche Inc.
3060
3
Bayer Healthcare AG
271
3
Other owners 188